Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Chai Chee Shee (Petaling Jaya, Malaysia), Chai Chee Shee, Liam Chong Kin, Pang Yong Kek, Kow Keng Siong, Poh Mau Ern, Wong Chee Kuan, Tan Jiunn Liang. Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients. Eur Respir J 2016; 48: Suppl. 60, 4840

Member's Comments

No comment yet.

Related content which might interest you: Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Gefitinib versus erlotinib as first-line treatment in EGFR mutant advanced lung adenocarcinoma Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Poor prognostic factors in advanced pulmonary adenocarcinoma patients receiving first-line gefitinib Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Surgical treatment outcomes on early-stages of non-small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy? Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 The prognostic value of the tumor shrinkage rate for progression-free survival in patients with non-small cell lung cancer receiving gefitinib Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC) Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Influence of neoadjuvant therapy to complication rate after surgery for primary lung cancer Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Treatment of advanced non-small cell lung cancer with trofosfamide Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Prognostic factors for survival in lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Characteristics of smoking behaviour in patients post-curative resection of stage 1 lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Electrospray-mediated local chemotherapy of lung carcinoma in mice Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Completion pneumonectomy for lung cancer relapse after surgery- What is a real benefit? Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Contribution of adjuvant chemotherapy in stage I pulmonary adenocarcinoma after surgical resection Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016